Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
法国肿瘤早期临床试验机会不平等因素:EGALICAN-2 研究结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.101610
Charton, E; Baldini, C; Fayet, Y; Schultz, E; Auroy, L; Vallier, E; Italiano, A; Robert, M; Coquan, E; Isambert, N; Moreau, P; Touzeau, C; Le Tourneau, C; Ghrieb, Z; Kiladjian, J-J; Delord, J-P; Gomez Roca, C; Vey, N; Barlesi, F; Lesimple, T; Penel, N; Soria, J-C; Massard, C; Besle, S